Allen Capital Group LLC Grows Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Allen Capital Group LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 607 shares of the medical equipment provider’s stock after acquiring an additional 48 shares during the period. Allen Capital Group LLC’s holdings in Intuitive Surgical were worth $317,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Mirador Capital Partners LP lifted its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the fourth quarter valued at $82,517,000. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, Consolidated Planning Corp increased its stake in Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.2 %

NASDAQ:ISRG opened at $572.71 on Thursday. The stock’s 50-day moving average is $548.70 and its 200-day moving average is $507.04. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a market cap of $203.99 billion, a P/E ratio of 92.08, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday. Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday. Raymond James raised their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock valued at $15,357,560 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.